Harlan Pinto
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Oncology
- Associate Professor - Med Center Line (By courtesy), Otolaryngology (Head and Neck Surgery)
- Member, Cancer Center
Contact Information
-
Clinical Offices
Medical Oncology 875 Blake Wilbur Dr Clinic B MC 5820 Stanford, CA 94305-5820 Tel Work (650) 498-6000 Fax (650) 853-8024Otolaryngology - Head/Neck Surgery 875 Blake Wilbur Dr Clinic B Stanford, CA 94305-5820 Tel Work (650) 498-6000 Fax (650) 725-9113
Professional Snapshot
Clinical Focus
- Cancer > Head and Neck Cancer
- Esophageal Cancer
- Esophageal Cancer - Medical Oncology
- Head and Neck Cancers
- Head and Neck Cancers - Medical Oncology
Professional Education
| Residency: | Massachusetts General Hospital, MA (1986) |
| Internship: | Massachusetts General Hospital, MA (1984) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (1991) |
| Fellowship: | SUMC - Graduate Medical Education, CA (1991) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1986) |
Scientific Focus
Research Interests
Clinical investigations focus on head and neck cancer with a particular interest in combined modality therapy. Through the Stanford University Head and Neck Tumor Board, clinical trials are conducted which involve all aspects of care for patients with head and neck cancer. The clinical research program includes translation of preclinical work performed in the Radiobiology Section at Stanford, new drug development, the development of novel combination therapy, chemoprevention, and the integration of biological response modifiers into combined modality treatment.
As a member of Stanford’s Eastern Cooperative Oncology Group trials effort, Dr. Pinto is involved in the implementation and development of a variety of clinical trials at Stanford and the Palo Alto Veterans Affairs Medical Center.
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Recruiting
- Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery Recruiting
- Ph III Randomized Study of Four Weeks of High-Dose IFN-á2b for Microscopic Melanoma Recruiting
- Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer Recruiting
- Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Recruiting
Publications
- Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008; (2): 393-400
- In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2008; (4): 1151-7
- Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; (4): 261-9
- Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med. 2007: 58S-67S
- Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck. 2007; (3): 211-20
Trial Administration